4/12
08:01 am
gthx
G1 Therapeutics, Inc. (NASDAQ: GTHX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.
Low
Report
G1 Therapeutics, Inc. (NASDAQ: GTHX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.
4/12
05:58 am
gthx
Rating for GTHX
Low
Report
Rating for GTHX
4/12
05:58 am
gthx
Rating for GTHX
Low
Report
Rating for GTHX
2/28
05:12 pm
gthx
G1 Therapeutics, Inc. (NASDAQ: GTHX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $5.00 price target on the stock, up previously from $4.00.
Low
Report
G1 Therapeutics, Inc. (NASDAQ: GTHX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $5.00 price target on the stock, up previously from $4.00.
2/28
05:12 pm
gthx
G1 Therapeutics, Inc. (NASDAQ: GTHX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $5.00 price target on the stock, up previously from $4.00.
Low
Report
G1 Therapeutics, Inc. (NASDAQ: GTHX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $5.00 price target on the stock, up previously from $4.00.
2/28
12:14 pm
gthx
G1 Therapeutics, Inc. (NASDAQ: GTHX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.
Medium
Report
G1 Therapeutics, Inc. (NASDAQ: GTHX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.
2/28
11:43 am
gthx
Rating for GTHX
Medium
Report
Rating for GTHX
2/28
11:43 am
gthx
Rating for GTHX
Medium
Report
Rating for GTHX
2/13
08:25 am
gthx
Rating for GTHX
High
Report
Rating for GTHX
2/13
08:25 am
gthx
Rating for GTHX
High
Report
Rating for GTHX
2/13
07:01 am
gthx
Rating for GTHX
High
Report
Rating for GTHX
2/13
07:01 am
gthx
Rating for GTHX
High
Report
Rating for GTHX
1/24
08:12 am
gthx
G1 Therapeutics, Inc. (NASDAQ: GTHX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $14.00 price target on the stock.
Medium
Report
G1 Therapeutics, Inc. (NASDAQ: GTHX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $14.00 price target on the stock.
1/24
05:37 am
gthx
Rating for GTHX
Low
Report
Rating for GTHX
1/24
05:37 am
gthx
Rating for GTHX
Low
Report
Rating for GTHX